Table of Contents Table of Contents
Previous Page  212 / 1851 Next Page
Information
Show Menu
Previous Page 212 / 1851 Next Page
Page Background

Endpoints

•

Primary:

Safety

•

Secondary:

Humoral immunogenicity

Cell-mediated immunogenicity

Impact of escalating doses of HER2

G. Curigliano et al. 2016

1 … 207 208 209 210 211 212 213 214 215 216 217 218 … 1851  FlippingBook